Thomas Lion Selected Research

Thomas Lion Research Topics

Disease

12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2008
11	Infections 01/2023 - 08/2003
9	Neoplasms (Cancer) 02/2024 - 06/2002
6	Virus Diseases (Viral Diseases) 01/2021 - 10/2005
5	Adenoviridae Infections (Adenovirus Infections) 05/2018 - 07/2006
4	Leukemia 12/2023 - 04/2016
3	Mycoses (Diseases, Fungus) 11/2023 - 01/2021
3	Disease Progression 01/2019 - 04/2010
3	Common Cold 01/2014 - 09/2012
2	Hematologic Neoplasms (Hematological Malignancy) 07/2023 - 03/2021
2	Viremia 01/2021 - 05/2014
1	Neuroblastoma 02/2024
1	Aspergillosis 01/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Blast Crisis (Blast Phase) 01/2021
1	Fever (Fevers) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 12/2020
1	Hypersensitivity (Allergy) 01/2020
1	COVID-19 01/2020
1	Inflammation (Inflammations) 12/2018
1	Communicable Diseases (Infectious Diseases) 05/2018
1	Cytomegalovirus Infections (Inclusion Disease) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Epstein-Barr Virus Infections 07/2015
1	Body Weight (Weight, Body) 05/2014
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 04/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 04/2013
1	Coinfection 09/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012
1	Philadelphia Chromosome 06/2010
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 05/2009
1	Brain Neoplasms (Brain Tumor) 07/2007
1	Oligodendroglioma 07/2007
1	Ependymoma 07/2007
1	Glioblastoma (Glioblastoma Multiforme) 07/2007
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 05/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2005
1	Bronchiolitis Obliterans Syndrome 10/2005
1	Latent Infection 12/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2002
1	Anaplasia 06/2002

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2012
5	Imatinib Mesylate (Gleevec)FDA Link 12/2020 - 06/2010
4	Phosphotransferases (Kinase)IBA 12/2023 - 11/2016
4	Antiviral Agents (Antivirals)IBA 12/2019 - 09/2012
3	RNA (Ribonucleic Acid)IBA 02/2024 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 12/2004
3	CarrageenanIBA 01/2014 - 09/2012
3	Nasal SpraysIBA 01/2014 - 09/2012
2	Messenger RNA (mRNA)IBA 01/2022 - 02/2015
2	ponatinibIBA 01/2021 - 12/2019
2	InterferonsIBA 12/2020 - 04/2014
2	Cidofovir (Vistide)FDA Link 05/2014 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 04/2014 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 06/2012 - 07/2007
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2005 - 10/2005
1	Proline (L-Proline)FDA Link 11/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	CytokinesIBA 01/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	asciminibIBA 01/2021
1	LigandsIBA 12/2020
1	Activin Receptors (Activin Receptor)IBA 12/2020
1	poly(lactide) (polylactic acid)IBA 01/2020
1	Drug CombinationsIBA 01/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 02/2015
1	Protein Isoforms (Isoforms)IBA 02/2015
1	SolutionsIBA 09/2012
1	PolymersIBA 09/2012
1	Sodium Chloride FDA LinkGeneric 09/2012
1	Viral DNAIBA 06/2012
1	nilotinib FDA Link 06/2012
1	EnzymesIBA 01/2012
1	ProdrugsIBA 01/2012
1	EWS-FLI fusion proteinIBA 04/2010
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2006

Therapy/Procedure

15	Therapeutics 07/2023 - 06/2002
11	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2005
8	Stem Cell Transplantation 01/2021 - 08/2003
3	Immunotherapy 01/2023 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2002
2	Transplantation 05/2018 - 01/2016
1	Precision Medicine 03/2021
1	Homologous Transplantation 12/2020
1	Complementary Therapies (Alternative Medicine) 12/2020
1	Personal Protective Equipment 01/2020
1	Investigational Therapies (Experimental Therapy) 12/2018
1	Ligation 04/2016
1	ICE protocol 4 01/2014